Appointment of Chief Operating Officer

RNS Number : 0989S

Cambridge Cognition Holdings PLC

07 March 2019

 

7 March 2019

Cambridge Cognition Holdings Plc

("Cambridge Cognition" or the "Company")

Appointment of Chief Operating Officer

Cambridge Cognition Holdings plc ('the Company'), which develops and markets neuroscience technology to assess brain health, is pleased to announce that Dr. Matthew Stork has agreed to join the Company as Chief Operating Officer on completion of the fundraise announced earlier today. 

Matthew has expertise in a broad range of healthcare sectors including healthcare IT, diagnostic imaging, clinical service delivery, capital devices and pharmaceuticals. He has held executive roles at InHealth Group, General Electric, ArjoHuntleigh, Toshiba Medical and Smith and Nephew.   It is expected that Matthew will join the Board of Directors of the Company in due course. 

Commenting Steven Powell, Chief Executive Officer, said:

"We are delighted to welcome Matthew to Cambridge Cognition - he has extensive experience in digital health and has been successful in driving growth and shareholder value. Matthew will play a key role in driving our penetration of cognitive and clinical assessment markets and to forming strong relationships with corporate partners. Matthew joins us at an exciting time - we have a record level of contracted revenue and substantial demand for our innovative offerings which will provide a platform for growth." 

Enquiries:

Cambridge Cognition Holdings plc		www.cambridgecognition.com
Steven Powell, Chief Executive Officer		Tel: [phone]
Nick Walters, Chief Financial Officer		[e-mail]
finnCap Ltd (Nomad and Joint Broker)		Tel: [phone]
Geoff Nash / Simon Hicks		(Corporate Finance)
Alice Lane		(Corporate Broking)
Dowgate Capital Limited (Joint Broker)	Tel: [phone]
David Poutney / James Serjeant
IFC Advisory Ltd (Financial PR and IR) Graham Herring / Miles Nolan / Zach Cohen	Tel: [phone]

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

 

END

 

 

MSCFMGGFGVNGLZZ